A randomized, double-blind, placebo-controlled proof-of-concept study of ondansetron for bipolar and related disorders and alcohol use disorder

Bipolar disorder is associated with high rates of alcohol use disorder. However, little is known about the treatment of this dual diagnosis population. Previous studies suggest that ondansetron decreases alcohol use, particularly in people with specific single nucleotide polymorphism (SNP) alleles....

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European neuropsychopharmacology 2021-02, Vol.43, p.92-101
Hauptverfasser:	Sherwood Brown, E., McArdle, Meagan, Palka, Jayme, Bice, Collette, Ivleva, Elena, Nakamura, Alyson, McNutt, Markey, Patel, Zena, Holmes, Traci, Tipton, Shane
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Alcohol Drinking Alcohol use Alcoholism - drug therapy Bipolar Bipolar Disorder - drug therapy Double-Blind Method Humans Male Middle Aged Ondansetron Ondansetron - therapeutic use Psychiatric Status Rating Scales Symptom severity Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!